¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ The 17th Postgraduate Course of Diabetes : 2018-09-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ The 17th Postgraduate Course of Diabetes : 2018-09-15 
±³À°ÀÏÀÚ : 2018-09-15
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ÄÁº¥¼Ç¼¾ÅÍ ±¤°³Åä°ü ÁöÇÏ1Ãþ ÄÁÆÛ·±½º·ë1  
±³À°ÁÖÁ¦ : The 17th Postgraduate Course of Diabetes      
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ±èÁ¤Èñ
¿¬¶ôó : 02-714-9081  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 45ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï 30,000¿ø / ÇöÀåµî·Ï 40,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 09:00~09:30 Inpatient management of diabetes  Á¶¿µ¹Î((¼­¿ïÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 09:30~09:55 Diabetes management in patients with liver disease & renal disease  ±è¼ÒÇå((ÀÎÇÏÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 09:55~10:20 The management of the elderly diabetic patient  ¹ÚÁ¤Çö((ÀÎÁ¦ÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 10:20~10:45 Management of diabetes in pregnancy  ¹®¹Î°æ((¼­¿ïÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 11:05~11:35 A Strategy for Diabetes Treatment Using Artificial Pancreas  Á¶ÀçÇü ((°¡Å縯ÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 11:35~12:05 Recent advances in continuous glucose monitoring  ±èÀçÇö((¼º±Õ°üÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 12:05~12:35 New drugs for the treatment of diabetes  ÃÖö¼ö((°¡ÃµÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 13:40~14:10 Cardiovascular complications  ½ÉÁö¿µ((¿¬¼¼ÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 14:10~14:40 Diagnosis of diabetic retinopathy update: "deep eye"  ¼Û¼öÁ¤((¼º±Õ°üÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 14:40~15:10 Diabetic neuropathy  À±Àç½Â ((°¡Å縯ÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 15:20~15:50 Should metformin remain the first-line therapy for type 2 diabetes?  È«»ó¸ð((ÇѸ²ÀÇ´ë)) 
±³À°½Ã°£ 09¿ù 15ÀÏ ÄÁÆÛ·±½º·ë 1 15:50~16:20 New ADA/EASD consensus for the management of type 2 diabetes  ÀÌ¿ìÁ¦((¿ï»êÀÇ´ë)) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ The 17th Postgraduate Course of Diabetes : 2018-09-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °Ç±¹´ëÇб³º´¿ø ´ëÇѳú½Å°æÀçÈ°ÇÐȸ 2018³âµµ Ã߰迬¼ö°­Á : 2018-09-15
´ÙÀ½±Û Á¦11Â÷ ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ ½ÉÆ÷Áö¾ö : 2018-09-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 5 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 9 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 4 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 7 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 4 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 9 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 6 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 2 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 2 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 3 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 6 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 2 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 6 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 2 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 6 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷